These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 36303829)

  • 21. Comprehensive analysis of a novel signature incorporating lipid metabolism and immune-related genes for assessing prognosis and immune landscape in lung adenocarcinoma.
    Wang Y; Xu J; Fang Y; Gu J; Zhao F; Tang Y; Xu R; Zhang B; Wu J; Fang Z; Li Y
    Front Immunol; 2022; 13():950001. PubMed ID: 36091041
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Comprehensive Analysis of the Transcriptome-wide m6A Methylome in Lung Adenocarcinoma by MeRIP Sequencing.
    Mao W; Yu Q; Wang K; Ma Q; Zheng Y; Zhang G; Luo W; Wang N; Wang Y
    Front Oncol; 2022; 12():791332. PubMed ID: 35903698
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Deciphering N
    Zhu J; Wang M; Hu D
    Biomed Res Int; 2020; 2020():2514230. PubMed ID: 32258108
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Analysis of m
    Zeng QC; Sun Q; Su WJ; Li JC; Liu YS; Zhang K; Yang LQ
    Sci Rep; 2022 Nov; 12(1):20684. PubMed ID: 36450735
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Tumor microenvironment related novel signature predict lung adenocarcinoma survival.
    Chen J; Zhou R
    PeerJ; 2021; 9():e10628. PubMed ID: 33520448
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Construction of a lung adenocarcinoma prognostic model based on N6-methyl-adenosine-related long noncoding RNA and screening of potential drugs based on this model.
    Hou Q; Zhong Y; Liu L; Wu L; Liu J
    Anticancer Drugs; 2022 Apr; 33(4):371-383. PubMed ID: 35213857
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Cancer Stemness-Based Prognostic Immune-Related Gene Signatures in Lung Adenocarcinoma and Lung Squamous Cell Carcinoma.
    Li N; Li Y; Zheng P; Zhan X
    Front Endocrinol (Lausanne); 2021; 12():755805. PubMed ID: 34745015
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Risk stratification of lung adenocarcinoma using a nomogram combined with ferroptosis-related LncRNAs and subgroup analysis with immune and N6-methyladenosine modification.
    Gao C; Kong N; Zhang F; Tang T; Li J; Ding H; Sun Z; Wu L; Xu M
    BMC Med Genomics; 2022 Jan; 15(1):15. PubMed ID: 35093068
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Lipid metabolism gene-wide profile and survival signature of lung adenocarcinoma.
    Li J; Li Q; Su Z; Sun Q; Zhao Y; Feng T; Jiang J; Zhang F; Ma H
    Lipids Health Dis; 2020 Oct; 19(1):222. PubMed ID: 33050938
    [TBL] [Abstract][Full Text] [Related]  

  • 30. A novel glycosylation-related gene signature predicts survival in patients with lung adenocarcinoma.
    Liang JX; Chen Q; Gao W; Chen D; Qian XY; Bi JQ; Lin XC; Han BB; Liu JS
    BMC Bioinformatics; 2022 Dec; 23(1):562. PubMed ID: 36575396
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Expression and Prognostic Significance of m6A-Related Genes in Lung Adenocarcinoma.
    Zhang Y; Liu X; Liu L; Li J; Hu Q; Sun R
    Med Sci Monit; 2020 Feb; 26():e919644. PubMed ID: 32086933
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Expression Status and Prognostic Value of m
    Li X; Feng Z; Wang R; Hu J; He X; Shen Z
    Life (Basel); 2021 Jun; 11(7):. PubMed ID: 34206803
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Prognostic significance of pyroptosis-related factors in lung adenocarcinoma.
    Lin X; Zhou T; Hu S; Yang L; Yang Z; Pang H; Zhou X; Zhong R; Fang X; Yu Z; Hu K
    J Thorac Dis; 2022 Mar; 14(3):654-667. PubMed ID: 35399245
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Development and Validation of a Prognostic N6-Methyladenosine-Related Immune Gene Signature for Lung Adenocarcinoma.
    Zhang L; Luo Y; Cheng T; Chen J; Yang H; Wen X; Jiang Z; Li H; Pan C
    Pharmgenomics Pers Med; 2021; 14():1549-1563. PubMed ID: 34876833
    [TBL] [Abstract][Full Text] [Related]  

  • 35. RNA-Binding Protein IGF2BP1 Associated With Prognosis and Immunotherapy Response in Lung Adenocarcinoma.
    Liu J; Li Z; Cheang I; Li J; Zhou C
    Front Genet; 2022; 13():777399. PubMed ID: 35154270
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Genomics and Prognosis Analysis of N
    Ma Y; Zhang H
    Front Genet; 2021; 12():746666. PubMed ID: 34956315
    [No Abstract]   [Full Text] [Related]  

  • 37. Construction and validation of a novel prognostic signature of microRNAs in lung adenocarcinoma.
    Li W; Liu S; Su S; Chen Y; Sun G
    PeerJ; 2021; 9():e10470. PubMed ID: 33510968
    [TBL] [Abstract][Full Text] [Related]  

  • 38. KIAA1429 promotes the progression of lung adenocarcinoma by regulating the m6A level of MUC3A.
    Zhao W; Xie Y
    Pathol Res Pract; 2021 Jan; 217():153284. PubMed ID: 33249400
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Development and validation of a nomogram with an epigenetic signature for predicting survival in patients with lung adenocarcinoma.
    Wang J; He L; Tang Y; Li D; Yang Y; Zeng Z
    Aging (Albany NY); 2020 Nov; 12(22):23200-23216. PubMed ID: 33221751
    [TBL] [Abstract][Full Text] [Related]  

  • 40. A ferroptosis-related gene signature predicts overall survival in patients with lung adenocarcinoma.
    Gao X; Tang M; Tian S; Li J; Liu W
    Future Oncol; 2021 Apr; 17(12):1533-1544. PubMed ID: 33432837
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.